Health Condition 1: K869- Disease of pancreas, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
UNIVERSITY HOSPITAL HALLE
Eligibility
Inclusion criteria
Inclusion criteria: Consecutive patients undergoing elective multivisceral oncological resections involving the pancreas between January 1st 2010 and December 31st 2022 will be included
Exclusion criteria
Exclusion criteria: patients who underwent isolated pancreatic resection for pancreatic metastasis or revision pancreatectomies will be excluded from this analysis Patients who were not undergoing oncological resections e g traumatic lesions or those who did not undergo surgery as curative intent will be also excluded from the study Patients with incomplete data incomplete/not mentioned on EMR will be excluded from this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine factors associated with morbidity, mortality, overall survival and diseasefree survival. Timepoint: For overall and diseases free survival timepoint is 5 years and for mobidity and motality timepoint is 90 days after the surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease-Free Survival (DFS) / Recurrence-Free Survival ? Based on recurrence data. Timepoint: 5 years after the surgery;Morbidity and Mortality Rates Including 90 day mortality and postoperative complications classified by Clavien-Dindo. Timepoint: 90 days after the surgery;Postoperative Specific ComplicationsTimepoint: 90 days after the surgery | — |
Countries
China, Germany, India, Ireland, Italy, Turkey, United Kingdom
Contacts
Public ContactDr Shailesh Shrikhande
TATA MEMORIAL HOSPITAL
Outcome results
None listed